U.S. Chemicals Stock News

NasdaqCM:TAYD
NasdaqCM:TAYDMachinery

Taylor Devices (TAYD) Stock Rallies On Margin Strength As Revenue Retreats

Taylor Devices stock added 3.2% in regular trading to close at US$57.70, even as the latest quarter showed thinner revenue and earnings than earlier in the year. The market is leaning into the story of a company that still carries a trailing P/E of 21.7x and a trailing net profit margin of 20.6%, and it is treating this print as confirmation rather than a warning. For investors, the headline is simple: the quarter was softer on the top and bottom line, yet the sentiment around Taylor Devices...
NYSE:CB
NYSE:CBInsurance

Chubb (CB) Stock Could Be A Bargain On Fair Value Yet Fully Priced On Earnings

Chubb stock has almost doubled over the past five years, yet the latest intrinsic value work using an Excess Returns model points to a sizeable discount to where the shares trade today, even as earnings based multiples look broadly in line with the market. Chubb has returned 96.6% over five years, which puts current holders in a strong position and raises the question of how much value is left on the table. Future cash flow generation from Chubb's underwriting and investment operations can...
NYSE:YOU
NYSE:YOUSoftware

Dutch Bros Stock And Other Cash Flow Picks Trading Below Fair Value

Central banks are keeping interest rates restrictive as they try to contain stubborn inflation, which keeps borrowing costs higher and puts pressure on company valuations. That is pushing many investors toward the sidelines. It also creates a window for those willing to look at cash flow. This article walks through three stocks from the Undervalued Stocks Based On Cash Flows screener that currently trade below SWS fair value estimates. The three stocks that follow are just a starting sample,...
NasdaqGS:COST
NasdaqGS:COSTConsumer Retailing

Is Costco Wholesale (COST) Above Fair Value After Its Medicare Push?

Costco Wholesale stock has delivered a strong 123.8% total return over the past 5 years, yet the current valuation checks now lean expensive rather than clearly cheap. The 123.8% 5 year return highlights how strongly Costco Wholesale has rewarded long term shareholders. This raises the bar for what the current price implies about the future. Expansion into Medicare plans through SCAN Group can support the long term growth story, while uncertainty around tariff refund obligations and related...
NYSE:FHI
NYSE:FHICapital Markets

Short Term Bond Funds Gain Appeal As Fed Rate Bets Shift

The latest Fed minutes and shifting hike expectations have suddenly put short term interest rates back in the spotlight. That matters if you care about how inflation, policy error risk and bond yields can reshape the appeal of short maturity investment grade corporate bond funds. This article walks through three stocks exposed to this news and explains how each might benefit or face pressure as the rate story evolves into year end. The three fund stocks covered below are just a starting...
NYSE:BLCO
NYSE:BLCOMedical Equipment

Did Bausch + Lomb’s (BLCO) Board Overhaul Amid Weak Returns Just Shift Its Investment Narrative?

On 5 August 2026, Bausch + Lomb Corporation reshaped its board by appointing four new directors to replace four resigning members, including experienced leaders from healthcare, asset management and private investment firms. This board overhaul comes as the company contends with rising capital intensity, lower free cash flow margins and a 1.5% return on capital, highlighting governance as a key lever for tackling operational challenges. Next, we’ll examine how this boardroom refresh, amid...
NYSE:GENI
NYSE:GENIHospitality

Did Raised 2026 Revenue Guidance Amid Losses Just Shift Genius Sports' (GENI) Investment Narrative?

In August 2026, Genius Sports reported second-quarter 2026 results showing sales of US$195.5 million and a net loss of US$76.73 million, while also issuing third-quarter guidance for about US$260 million in group revenue. At the same time, the company raised its full-year 2026 revenue outlook to a range of US$1.01 billion to US$1.03 billion, signaling management’s increased confidence in its current growth trajectory despite ongoing losses. Next, we’ll examine how this higher full-year...
NasdaqGS:VNET
NasdaqGS:VNETIT

VNET Group (VNET) Stock Rises On AI Backlog As Losses Deepen

VNET Group shares were up 3.3% today, a bright spot after a tough three months that left the stock down more than 30%. The move came as investors focused on a sharp rebound in profitability metrics rather than headline losses. Adjusted earnings before interest, tax, depreciation and amortization reached RMB 918.3m on revenue of RMB 2.78b, with wholesale data center capacity now past 1 gigawatt in service. The near term still carries pressure, given ongoing losses and a limited cash runway...
NYSE:CAAP
NYSE:CAAPInfrastructure

Corporación América Airports (NYSE:CAAP) Stock Rises Despite Deepening Margin Squeeze

Corporación América Airports came into this earnings print with the stock down over the past quarter, yet the immediate reaction told a different story. Shares ticked up about 1.4% to US$23.31 after the Q2 release, as investors focused less on the headline dip in earnings per share to US$0.32 and more on what the income statement and cash position say about staying power. The real story this quarter sits in margins and profit pressure. Adjusted earnings before interest, tax, depreciation and...
NYSE:NLY
NYSE:NLYMortgage REITs

Does Annaly’s Series I Preferred Redemption Reshape Its Capital Allocation Story For NLY Investors?

Annaly Capital Management, Inc. recently declared third-quarter 2026 cash dividends on its Series F, G, I and J preferred shares, with payouts scheduled for September 30, 2026 to holders of record on September 1, 2026. At the same time, Annaly moved to redeem all outstanding Series I preferred shares at US$25.00 each on October 1, 2026, signaling an adjustment in its capital structure and funding mix. We’ll now examine how the full redemption of the Series I preferred shares may influence...
NYSE:EL
NYSE:ELPersonal Products

Estée Lauder (EL) Stock Still Looks Undervalued On Its 68% Slump

Estée Lauder Companies has delivered a steep 68.5% share price decline over the past five years, yet the current intrinsic value estimate based on a Discounted Cash Flow (DCF) approach suggests the stock trades at a 24.6% discount to that value, while broader valuation checks point to only a mixed picture rather than a clear bargain. The 68.5% share price decline over five years raises the question of whether Estée Lauder Companies is now pricing in too much pessimism or whether it reflects...
NYSE:VPG
NYSE:VPGElectronic

Vishay Precision Group (VPG) Tests The Bull Case On Industry 4.0 Valuation Narrative

Vishay Precision Group (VPG) stock has drawn fresh attention after recent trading moves, with the price closing at $63.13 on 18 August 2026. Investors are weighing this level against its historical total return profile. See our latest analysis for Vishay Precision Group. For context, Vishay Precision Group’s share price has recently fallen 39.3% over three months and 38.4% over the past month, yet the year-to-date share price return is 60.7% and the 1-year total shareholder return is 133.5%...
NYSE:MTN
NYSE:MTNHospitality

Epic Pass Push And Experience Upgrades Might Change The Case For Investing In Vail Resorts (MTN)

Vail Resorts recently outlined its now-past opening dates lineup for the 2026/27 winter season, promoted Epic Pass sales ahead of a September 7 price increase, and highlighted new guest experiences under its Epic Experience growth strategy. Significant upgrades at flagship resorts like Whistler Blackcomb, including lift improvements, dining enhancements, and expanded services, underscore the company’s focus on boosting guest appeal and advance commitment. We’ll now examine how these new...
NYSE:GRDN
NYSE:GRDNHealthcare

The Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Upbeat Q2 Results And Higher 2026 Guidance - Learn Why

In August 2026, Guardian Pharmacy Services, Inc. reported past second-quarter 2026 results showing sales of US$351.77 million and net income of US$21.87 million, both higher than the prior year, alongside stronger first-half figures. On the same day, the company also raised its full-year 2026 revenue guidance to US$1.43–1.45 billion, highlighting management’s increased confidence in its operating performance. We’ll now examine how this guidance upgrade, alongside stronger quarterly...
NasdaqGS:AFRM
NasdaqGS:AFRMDiversified Financial

Affirm (AFRM) Stock Looks Above Fair Value After Its 433% Run

Affirm Holdings has delivered a very large 432.9% return over the last three years, yet Simply Wall St's intrinsic value estimate and market multiple checks both flag the stock as expensive relative to fundamentals. Over the past three years, Affirm Holdings has returned 432.9%, which sets expectations high for what comes next. Recent upbeat analyst sentiment and strong revenue momentum can support elevated expectations, while any disappointment around growth durability or credit performance...
NasdaqGS:XP
NasdaqGS:XPCapital Markets

XP (NasdaqGS:XP) Stock Rally Masks Slower Profit Growth Concerns

XP stock closed up 4.4% at $16.53, even though the story today sits less in the price chart and more in the income statement. The market is cheering, yet the key question for you is whether the earnings justify that relief rally or reflect buyers leaning on optimism. The headline is clear. XP reported another quarter of solid profit with basic earnings per share of 2.71 BRL and adjusted net income of 1.4b BRL, while keeping return on equity at 22.5%. That mix of earnings power and...
NYSE:BMY
NYSE:BMYPharmaceuticals

Is Bristol-Myers Squibb (BMY) Fully Priced As FDA Approval And $2.3b Expansion Lift Outlook?

Bristol-Myers Squibb (BMY) is in focus after two related announcements. The FDA granted accelerated approval for its new multiple myeloma drug ZENBEXUS, and the company committed US$2.3b to a new Houston manufacturing campus. See our latest analysis for Bristol-Myers Squibb. These announcements arrive after a strong run for Bristol-Myers Squibb, with a 30 day share price return of 12.38% and a year to date share price return of 26.47%, while the 1 year total shareholder return is 46.82%. If...
NasdaqGS:CPB
NasdaqGS:CPBFood

Is Campbell's (CPB) Pairing New Shelf Capacity With Sauces And Ethics To Refresh Its Brand Narrative?

Earlier this month, Campbell's filed an omnibus shelf registration for a mix of capital stock, preferred stock, debt securities, warrants, purchase contracts, and units, while also rolling out new at-home cooking innovations such as Campbell's Condensed Sauces and expanding premium and snack offerings. At the same time, recognition from The Humane League for progressing on 100% cage-free egg commitments underscores how Campbell's is pairing product innovation with evolving ethical sourcing...
NYSE:AXP
NYSE:AXPConsumer Finance

Will Embedding Virtual Cards Into @ Work and Travel Workflows Change American Express' (AXP) Narrative

Earlier this month, American Express expanded its U.S. commercial offering by integrating Virtual Card issuance and management into its @ Work platform and extending mobile Virtual Card capabilities for Business Travel Account customers through Conferma. This move deepens American Express’s role inside corporate finance and travel workflows by tying its Virtual Cards directly into ERP, expense tools, and controlled, policy-based spending for employees and non-cardholders. Next, we’ll examine...
NYSE:BG
NYSE:BGFood

How Revenue Growth Amid Margin Pressure Will Impact Bunge Global (BG) Investors

Recently, Bunge Global reported revenue growth but flagged pressure from shrinking demand and less profitable incremental sales, underscoring the commoditized nature of its core agribusiness and food operations. This tension between higher sales and constrained gross margins raises questions about how effectively Bunge Global can convert scale into sustainable profitability across its portfolio. We’ll now examine how these concerns about softer demand and thinner margins could reshape Bunge...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

How Merit’s Leadership Transition in Global Operations at Merit Medical Systems (MMSI) Has Changed Its Investment Story

Merit Medical Systems recently announced that Sheri Lewis, a veteran operations executive with three decades of experience at companies including Medtronic and Honeywell, joined as Executive Vice President of Global Operations on August 31, 2026. The planned handover, with long-serving COO Mr. Peterson remaining as Senior Advisor until March 5, 2027, underscores the company’s emphasis on maintaining operational continuity while refreshing its leadership bench. Next, we’ll examine how...
NYSE:YMM
NYSE:YMMTransportation

Full Truck Alliance (NYSE:YMM) Stock Sees Margin Strength Outrun Growth Doubts

Full Truck Alliance slipped about 1% to US$8.70 into the close, which looks modest next to the scale of what the business just put on the tape. The stock has drifted lower over the past month, yet the latest figures show one thing that really matters for a platform company in freight: the margin story is holding up. Net profit margin for the last twelve months sits in the low 30s, and transaction service revenue is taking a larger slice of the pie. That mix shift is the headline to focus on,...
NasdaqGS:PTEN
NasdaqGS:PTENEnergy Services

Is Patterson-UTI (PTEN) Using Its ESOP Shelf To Quietly Reshape Capital Structure And Incentives?

Patterson-UTI Energy recently filed a shelf registration for up to 28,900,000 common shares under its Employee Stock Ownership Plan, bringing this long-term incentive program and potential share issuance capacity into clearer focus for investors. This move highlights how employee ownership and equity-based compensation could influence Patterson-UTI’s capital structure, governance alignment, and flexibility to reward its workforce over time. Next, we’ll examine how this sizeable ESOP-related...
NasdaqGS:HWKN
NasdaqGS:HWKNChemicals

Hawkins (HWKN) Board Member Yi Faith Tang Resigns

Hawkins (NasdaqGS: HWKN) disclosed that Board member Yi "Faith" Tang has resigned from the company. The company stated that Tang's resignation was not due to any disagreement with Hawkins. The change affects the composition of Hawkins' Board and its corporate governance structure. For readers reviewing Hawkins and looking for more ideas in this space, the next useful step is to compare it with a broader set of resilient, lower-risk stocks through 77 resilient stocks with low risk...